Silo Pharma, Inc. (NASDAQ:SILO) Shares Sold by Renaissance Technologies LLC

Renaissance Technologies LLC decreased its stake in shares of Silo Pharma, Inc. (NASDAQ:SILO) by 83.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 37,500 shares of the company’s stock after selling 189,506 shares during the quarter. Renaissance Technologies LLC owned approximately 0.84% of Silo Pharma worth $33,000 as of its most recent SEC filing.

Silo Pharma Price Performance

NASDAQ:SILO opened at $0.81 on Friday. Silo Pharma, Inc. has a 12 month low of $0.71 and a 12 month high of $4.50. The firm has a market capitalization of $3.65 million, a PE ratio of -0.67 and a beta of 0.37. The business’s fifty day moving average price is $1.12 and its 200 day moving average price is $1.22.

Silo Pharma (NASDAQ:SILO) last announced its quarterly earnings results on Friday, March 28th. The company reported ($0.41) earnings per share for the quarter. The company had revenue of $0.02 million during the quarter. Silo Pharma had a negative net margin of 5,255.05% and a negative return on equity of 61.38%.

Silo Pharma Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.